Skip to main content

Table 2 Number of cases scoring differently by at least one score from baseline to the end of treatment phase 1 (T1)

From: Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy

Age group Affected cases Alteration in the score at least by 1 score [n (%)]
Worse No change Better
Up to 2 yr 12 0 (0) 0 (0) 12 (100)
2 to 4 yr 14 0 (0) 1 (7.1) 13 (92.9)
4 to 6 yr 21 0 (0) 2 (9.5) 19 (90.5)
6 to 12 yr 27 0 (0) 2 (7.4) 25 (92.6)
12 to 18 yr 17 0 (0) 0 (0) 17 (100)